Physician profile
Rajesh Malik
NPI 1871551630
$53,645.36
in general payments reported to CMS, 2019-2025
31 companies · $14K in 2025
The $14K reported for 2025 was more than what 85% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,704 · 2020: $1,991 · 2021: $3,788 · 2022: $2,980 · 2023: $7,079 · 2024: $22K · 2025: $14K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $17K · Food and Beverage: $14K · Travel and Lodging: $12K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $16,875.00 |
| Food and Beverage | $14,178.06 |
| Travel and Lodging | $12,129.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $13,125.00 | 2023-2024 | Carto 3 |
| Biosense Webster, INC. | $10,415.47 | 2019-2025 | Carto 3, Thermocool Sf, Visitag Surpoint External Processing Unit |
| Medtronic, INC. | $10,322.38 | 2021-2025 | Micra, Evera Mri Xt Dr Surescan, Cobalt Dr Mri Surescan |
| Boston Scientific Corporation | $7,327.29 | 2020-2025 | Farapulse, Watchman Flx, Watchman Access System |
| Abbott Laboratories | $4,597.85 | 2019-2025 | Aveir, Ensite Precision, Tacticath Ablation Catheter, Sensor Enabled |
| Atricure, INC. | $1,826.96 | 2019-2024 | |
| Biotronik INC. | $1,154.05 | 2019-2025 | Amvia Edge, Biomonitor |
| Medtronic Vascular, INC. | $954.19 | 2019-2020 | |
| Acutus Medical, INC. | $879.47 | 2020-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $709.00 | 2019-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $384.34 | 2020-2022 | |
| Cvrx, INC. | $313.03 | 2020-2025 | Barostim Neo System |
| Cardiofocus, INC. | $286.49 | 2022 | |
| Philips North America LLC | $214.57 | 2021-2023 | (9520) Igt Devices Undivided |
| Sanofi-Aventis U.S. LLC | $179.04 | 2019-2022 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kestra Medical Technology Services, INC. | $171.73 | 2022-2024 | Assure Wcd |
| Cardiva Medical, INC. | $159.03 | 2025 | Savvywire |
| Medicomp INC | $133.28 | 2023 | Telepatch Cardiac Monitor |
| Elutia, INC. | $102.39 | 2019-2024 | Ecm Patch,Pouch |
| Pfizer INC. | $67.17 | 2019-2023 | |
| Impulse Dynamics (USA) INC. | $61.69 | 2023-2024 | Optimizer, Optimizer |
| Cordis US Corp. | $57.84 | 2025 | Mynx Control Venous |
| Novartis Pharmaceuticals Corporation | $51.72 | 2019 | |
| Catheter Precision INC. | $31.90 | 2025 | |
| Amgen INC. | $26.49 | 2020 | |
| Bardy Diagnostics, INC. | $26.00 | 2020-2021 | |
| Ge Healthcare | $20.03 | 2020 | |
| Convatec INC. | $17.60 | 2024 | |
| Amarin Pharma, INC. | $15.12 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $14.24 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rajesh Malik listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.